To verify that similar results are observed when using clinical samples, DNA was isolated using the ACE chip from a lung cancer donor that had previously been characterized by solid tissue biopsy for the point mutations KRAS G12C and TP53 H193Y. Here, KRAS is linked to lung cancer.